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ABSTRACT 
Human plasma low density lipoprotein (LDL) that had been rendered polycati- 
onic by coupling with N,N-dimethyl-1,3-propanediamine (DMPA) was shown by 
electron microscopy to bind in clusters to the surface of human fibroblasts. The 
clusters resembled those formed by polycationic ferritin (DMPA-ferritin), a visual 
probe that binds to anionic sites on the plasma membrane. Biochemical studies 
with l~ZI-labeled DMPA-LDL showed that the membrane-bound lipoprotein was 
internalized and hydrolyzed in lysosomes. The turnover time for cell-bound 125I- 
DMPA-LDL,  i.e., the time in which the amount of I~ZI-DMPA-LDL  degraded 
was equal to the steady-state cellular content of the lipoprotein, was about 50 h. 
Because the DMPA-LDL gained access to fibroblasts by binding nonspecifically 
to anionic sites on the cell surface rather than by binding to the physiologic LDL 
receptor, its uptake failed to be regulated under conditions in which the uptake of 
native LDL was reduced by feedback suppression of the LDL receptor. As a 
result, unlike the case with native LDL, the DMPA-LDL accumulated progres- 
sively within the cell, and this led to a massive increase in the cellular content of 
both free and esterified cholesterol. Studies with 14C-oleate showed that at least 
20% of the accumulated cholesteryl esters represented cholesterol that had been 
esterified within the cell.  After 4  days of incubation with 10  /zg/ml of DMPA- 
LDL, fibroblasts had accumulated so much cholesteryl ester that neutral lipid 
droplets were visible  at the light microscope level with Oil Red O  staining. By 
electron microscopy, these intracellular lipid droplets were observed to lack a 
tripartite limiting membrane. The ability to cause the overaccumulation of choles- 
teryl esters within cells by using DMPA-LDL provides a model system for study of 
the pathologic consequences at the cellular level of massive deposition of choles- 
teryl ester. 
Normal human fibroblasts regulate their choles- 
terol content by controlling the rate of uptake of 
low density lipoprotein (LDL), the major choles- 
terol-rich lipoprotein in human plasma (10, 12, 
21). Control of this uptake  process is  achieved 
through regulation of the activity of a cell surface 
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before its internalization by adsorptive endocyto- 
sis (9, 28). When fibroblasts are deprived of exog- 
enous cholesterol,  cellular  cholesterol  stores be- 
come depleted, and the number of LDL receptors 
is  increased.  On  the  other  hand,  when  cellular 
cholesterol stores are expanded by exposure of the 
cells  to  an  exogenous source  of cholesterol,  the 
number of receptors is reduced by more than 90% 
(9, 28). This cholesterol-mediated feedback sup- 
pression of LDL receptor  activity serves to limit 
the uptake of LDL and thus to prevent the overac- 
cumulation of cholesterol by the cell (6, 9, 28). 
In order for the cholesterol of the internalized 
LDL  to  be  utilized  by  the  cell  for  membrane 
synthesis, the cholesteryl esters of the lipoprotein, 
which constitute about 70% of its total cholesterol 
content  (37),  must  first  be  hydrolyzed in  lyso- 
somes  (5,  14,  27).  The  resultant  lipoprotein- 
derived free cholesterol then becomes available to 
regulate three events in cellular steroi metabolism: 
(a) it suppresses endogenous cholesterol synthesis 
through  a  reduction  in  the  activity  of the  rate- 
controlling  enzyme  3-hydroxy-3-methylglutaryl 
coenzyme  A  reductase  (HMG  CoA  reductase) 
(3);  (b)  it  activates  a  microsomal  acyl- 
CoA:cholesterol  acyltransferase  that  serves  to 
reesterify  any  excess  free  cholesterol  that  is  de- 
rived from LDL so that it can be stored by the cell 
as cholesteryl esters (4, 25); and (c) it reduces the 
number of LDL receptors as mentioned above. 
Because of the efficiency of these control mech- 
anisms,  it  has  so far been  impossible  to  induce 
experimentally an overaccumulation of cholesteryl 
esters  in  human  fibroblasts  by  incubating  them 
with  plasma  LDL even  when  the  lipoprotein  is 
added at extremely high levels, i.e., at concentra- 
tions more than  30-fold above the level required 
to saturate the LDL receptors (6, 22). Recently, 
however, a method has been devised by which the 
uptake of LDL can be enhanced in human fibro- 
blasts through a mechanism that does not involve 
the LDL receptor (2).  This method involves the 
covalent  coupling of the  tertiary  amine  N,N-di- 
methyl-1,3-propanediamine (DMPA) primarily to 
the free carboxyl groups of the protein component 
of LDL,  thus  resulting  in  a  net increase  of two 
units of positive charge per carboxyl group modi- 
fied  and  changing  the  net  charge  of LDL from 
negative to positive (2). The conclusion that this 
polycationic  LDL  (DMPA-LDL)  entered  fibro- 
blasts  by  a  mechanism  that  bypassed  the  LDL 
receptor was supported by the finding that rapid 
uptake  and  degradation  of  this  modified  LDL 
occurred in cells  derived from a subject with the 
homozygous form  of familial  hypercholesterole- 
mia  (FH)  (2).  These  mutant  cells  have  been 
shown previously to possess a complete deficiency 
of functional cell surface LDL receptors as defined 
by both biochemical and ultrastructural criteria (1, 
7,  11,  13,  19,  20).  By  analogy  to  the  known 
behavior of polycationic ferritin (DMPA-ferritin) 
(15,  29),  which  binds  to  widespread  negatively 
charged sites on plasma membranes (39), we have 
postulated that DMPA-LDL binds to similar non- 
specific anionic sites  on the cell surface and that 
this membrane-bound lipoprotein is then taken up 
by endocytosis  and  delivered  to  lysosomes  (2). 
Since the hydrolysis of both the protein and cho- 
iesteryl ester components of DMPA-LDL was in- 
hibited by the iysosomal inhibitory agent chloro- 
quine,  it  was  concluded that  the  degradation  of 
this  modified  lipoprotein  occurred  in  lysosomes 
(2, 24, 27). 
The  current studies  were undertaken  with the 
following aims:  (a)  to characterize  the  chemical 
and  physical properties  of DMPA-LDL; (b)  to 
determine  by  means  of  electron  microscopy 
whether the DMPA-LDL does, in fact, bind to the 
plasma membrane; and (c) to determine whether 
human fibroblasts can be induced to accumulate 
nonphysiologic amounts of cholesteryl esters when 
incubated with  a modified lipoprotein whose up- 
take bypasses the LDL receptor and hence is not 
susceptible to normal feedback regulation. 
MATERIALS  AND  METHODS 
Materials 
DMPA  was  obtained  from  Eastman  Kodak  Co. 
(Rochester, N. Y.).  Ethylenediamine and 1-ethyl-3-(3- 
dimethylaminopropyl)-carbodiimide hydrochloride were 
products  of Aldrich  Chemical Co.,  Inc.  (Milwaukee, 
Wis.) and Pierce Chemical Co. (Rockford, Ill.), respec- 
tively. Cationized ferritin was obtained from Miles Labo- 
ratories, Inc. (Elkhart,  Ind.). Native ferritin and Harris 
hematoxylin stain were  purchased  from  Polysciences, 
Inc. (Warrington, Penn.).  Glutaraldehyde was obtained 
from Electron  Microscopy Sciences (Fort  Washington, 
Penn.).  Pronase  from  Streptomyces griseus,  B  grade 
(45,000  U/g)  was  obtained  from  Calbiochem  (San 
Diego, Calif.). Bio-gel A 15 M was obtained from Bio- 
Rad Laboratories (Richmond, Calif.). Bovine serum al- 
bumin  (catalog  no.  A4378)  and  chloroquine  diphos- 
phate  were  obtained  from  Sigma Chemical Co.  (St. 
Louis, Mo.).  Oil Red O was purchased from Chroma- 
GeseUschaft Schmid and  Co.  NCS Tissue Solubilizer, 
[U-14C]ethylenediamine  hydrochloride  (7.95  mCi/ 
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tained  from  Amersham/Searle  Corp.  (Arlington 
Heights, I11.). Sodium ~I-iodide (carder free in 0.05 N 
NaOH) was purchased from Schwarz/Mann Div., Bec- 
ton,  Dickinson  &  Co.  (Orangeburg,  N.  Y.).  Aquasol 
counting fluid was purchased from New England Nuclear 
(Boston, Mass.).  Fetal calf serum was purchased from 
Flow  Laboratories,  Inc.  (Rockville,  Md.).  Assay  re- 
agents for measuring triglycerides were  obtained from 
Boehringer-Mannheim  Biocbemicals  (Indianapolis, 
Ind.) (catalog no.  15989). Tissue culture supplies, thin- 
layer chromatographic materials, and reagents for assays 
were obtained from sources as previously reported (3, 
8). 
Cell Culture 
Cultured fibroblasts were derived from skin biopsies 
obtained from a  normal subject (D.  S.)  and a  patient 
with the receptor-negative form of homozygous FH (M. 
C.) (26). Cells were grown in monolayer and used be- 
tween the 5th and 20th passages.  Stock cultures were 
maintained in a humidified incubator (5% CO2) at 37~ 
in  250-ml  flasks containing  10  ml  of growth  medium 
consisting of Eagle's minimum essential medium (Grand 
Island Biological Co., Grand Island, N. Y., catalog no. 
F-11) supplemented with penicillin (100 U/ml), strepto- 
mycin  (100  /~g/ml),  20  mM  Tricine, pH  7.4,  24  mM 
NaHCO3,  1%  (vol/vol) nonessential amino acids,  and 
10% (vol/vol) fetal calf serum. Unless otherwise noted, 
all experiments were done in a similar format: On day 0, 
confluent  monolayers  of  cells  from  stock  flasks  were 
dissociated with 0.05% trypsin-0.02% EDTA solution, 
and  1  x  105 cells were seeded into each 60  ￿  15-ram 
Petri dish containing 3 ml of growth medium with 10% 
fetal calf serum.  On  day 3,  the  medium  was  replaced 
with  3  ml  of  fresh  growth  medium  containing  10% 
fetal calf serum. On day 5, each monolayer was washed 
with 3  ml of phosphate-buffered saline, after which 2 
ml  of  fresh  medium  containing  5%  (vol/vol)  human 
lipoprotein-deficient  serum  was  added  (final  protein 
concentration, 2.5  mg/ml). Experiments were initiated 
on day 7 after the cells had been incubated for 48 h in 
the presence of lipoprotein-deficient serum. 
Lipoproteins 
Human very low density lipoprotein (VLDL, density 
<1.006  g/ml), LDL,  (density  1.019-1.063  g/ml),  and 
lipoprotein-deficient serum (density >1.215 g/ml) were 
obtained from the plasma of healthy subjects and pre- 
pared by differential ultracentrifugation (3).  Calf lipo- 
protein-deficient serum was prepared as previously de- 
scribed (8). Unless otherwise noted, the concentrations 
of the lipoproteins are expressed in terms of their protein 
content. The mass ratio of cholesterol to protein in LDL 
was 1.6:1, as determined by gas-liquid chromatography 
(6). l~I-labeled LDL (sp act, 200-400 cpm/ng protein) 
was  prepared  as  previously  described  (7).  Cationized 
LDL  (DMPA-LDL)  was  synthesized  by  a  previously 
described method (2) that was based on the procedure 
originally described by Danon et al. for the cationization 
of ferritin (15).  DMPA-LDL  was  labeled with x25I as 
previously described (2). 
Biochemical Assays 
Measurements of the total cellular binding of ~I-LDL 
(20), the proteolytic degradation of 1~I-LDL (20), and 
the incorporation of 14C-oleate into cellular lipids (25) in 
intact  fibroblast  monolayers  were  carried  out  as  de- 
scribed in the referenced articles. The content of free and 
esterified cholesterol in fibroblasts was determined by a 
previously described method in which the steroids were 
extracted  from  washed  cell  pellets  with  chloro- 
form:methanol, the free and esterified cholesterol frac- 
tions were separated on silicic acid/Celite columns, and 
the cholesterol content in each fraction was measured by 
gas-liquid chromatography (6). The content of triglycer- 
ides  in  fibroblasts  was  determined  according  to  the 
method of Schmidt and von Dahl (36), using the Boeh- 
ringer-Mannheim triglyceride assay reagents. To extract 
triglycerides quantitatively from cells, each washed cell 
pellet (suspended in 0.2 ml water) was taken up in 5 ml 
of chloroform: methanol (2:1) (17), and the mixture was 
sonicated for 45 s and then extracted overnight at 37~ 
on a rotating platform. 
Protein Estimation 
The protein content of cell extracts and lipoproteins 
was determined by the method of Lowry et al.,  using 
bovine serum albumin as standard (32). Proteins coupled 
to DMPA gave a color reaction in the Lowry assay that 
was higher than could be accounted for by the known 
protein content of the sample. To correct for this DMPA 
effect,  the extent of the  increase in color reaction for 
DMPA-LDL was determined as follows: The cholesterol 
content and the "Lowry protein" content of a sample of 
t~I-labeled LDL were measured by gas-liquid chroma- 
tography and the Lowry method, respectively, and the 
specific radioactivity of the LDL (cpm/p.g protein) was 
calculated. This ~zSI-LDL preparation was then divided 
into three aliquots: one aliquot was reacted with DMPA 
under the standard cationization reaction conditions and 
then dialyzed,  the second aliquot was not treated with 
DMPA  but  was  dialyzed,  and  the  third  aliquot  was 
neither treated nor dialyzed. All three preparations were 
then assayed for their content of cholesterol, x25I-radio- 
activity, and Lowry  protein.  As shown in Table I,  all 
three preparations had a similar ratio of cholesterol con- 
tent  to  l~I-radioactivity content  (column  a).  On  the 
other hand,  the ratio of cholesterol content to Lowry 
protein content (column b) and the ratio of ~25I-radioac- 
tivity content to Lowry protein content (column c) were 
both about 1.5-fold lower in the DMPA-LDL prepara- 
tion than in the native LDL  preparations. These data 
indicated that the Lowry protein value for the DMPA- 
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Cholesterol:  Lowry Protein Ratio in Preparations of 
Native LDL and Cationized LDL 
Treatment of LDL 
(b) 
Choles- 
(a)  terol/  (c) 
Cholcs-  Lowry  pro-  ~2~I/Lowry 
terol/~I  rein  protein 
lag/cpm  tzg/~g  cpm/lag 
None  0.121  1.60  13.1 
Dialyzed  0.117  1.57  13.7 
Reacted with  0.123  1.07  8.7 
DMPA, then 
dialyzed 
A preparation of I~I-LDL (13.1  x  10  a cpm/mg protein) 
was analyzed for its content of cholesterol, nSI-radioac- 
tivity, and Lowry protein as described under Materials 
and Methods. One aliquot (20 mg protein) from the 1~I- 
LDL preparation was treated with DMPA as described 
under Materials and Methods. A  second aliquot of the 
same 125I-LDL preparation was treated similarly except 
that no carbodiimide or DMPA was added. Both LDL 
preparations were dialyzed for 18 h at 4~  against 6 liters 
of 0.15  M  NaC1,  pH  6.  After dialysis, the content of 
cholesterol,  ~I-radioactivity, and  Lowry protein were 
measured. Lowry protein refers to the apparent protein 
content as measured by the Lowry reaction using bovine 
serum albumin as a  standard. The values represent the 
ratios  of  cholesterol:  t~I-radioactivity;  cholesterol: 
Lowry protein; and ~25I-radioactivity: Lowry protein for 
each sample. Each measurement represents the mean of 
duplicate determinations. 
LDL was falsely elevated by a factor of 1.5. A  similar 
1.5-fold elevated ratio of Lowry protein to cholesterol 
was  consistently found in  three  other preparations of 
DMPA-LDL.  Accordingly, in the subsequent determi- 
nation of protein content of cationized protein prepara- 
tions, the value obtained by the Lowry protein method 
was divided by 1.5 to give the true protein content. 
Binding of Cationized Ferritin to the 
Cell Surface of Fibroblasts 
On  day  7  of cell growth, monolayers of fibroblasts 
were washed once with 3 ml of phosphate-buffered sa- 
line, after which 2 ml of 0.1 M  sodium phosphate, pH 
7.3  containing  320  p,g/ml  of  cationized  ferritin  was 
added  to  each  dish.  After exposure  to  the cationized 
ferritin for 10-20 s at room  temperature, each mono- 
layer was washed three times with 3  ml of phosphate- 
buffered saline and fixed in situ at room temperature for 
30 rain with 3% glutaraldehyde in 0.1  M sodium phos- 
phate buffer, pH 7.3 
Binding of Cationized LDL to the 
Cell Surface of Fibroblasts 
On  day  7  of cell growth, monolayers of fibroblasts 
were chilled to 4~  for 30 min, after which the medium 
from each dish was removed and replaced with 2 ml of 
ice-cold growth medium containing 5% human lipopro- 
tein-deficient serum and either native LDL or DMPA- 
LDL at a concentration corresponding to 9.4 /zg/ml  of 
LDL-protein.  After  incubation  at  4~  for  1  h,  each 
monolayer  was  washed  extensively  with  an  albumin- 
containing buffer (19). Each monolayer then received 2 
ml  of ice-cold  growth  medium  containing 5%  human 
lipoprotein-deficient serum and 5 mg/ml of native ferri- 
tin. After incubation at 4~  for 1 h, each monolayer was 
washed  five  times  with  3  ml  of  ice-cold  phosphate- 
buffered saline and fixed in situ at 4~  for 30 min with 
3% glutaraldehyde in 0.1  M  sodium phosphate buffer, 
pH 7.3. 
Electron Microscopy 
For the experiments showing the cell surface binding 
sites for cationized ferritin and DMPA-LDL (Figs. 2 and 
3), the fixed cells were washed in the original petri dish 
with phosphate-buffered saline and postfixed with 2% 
OsO4 in 0.1 M sodium phosphate buffer, pH 7.3. Cells 
were  dehydrated  through  a  graded  series  of  ethanol 
solutions,  washed  several  times  with  100%  ethanol, 
embedded in Epon (33), and prepared for thin section- 
ing as previously described (1). 
For the experiments showing the intracellular distribu- 
tion  of  lipid  in  cells  that  had  been  incubated  with 
DMPA-LDL (Fig. 8), the monolayers were fixed/n situ 
for 30  min with  3%  glutaraldehyde in 0.1  M  sodium 
phosphate buffer, pH 7.3, scraped from the dish with a 
rubber policeman, and centrifuged in a Beckman micro- 
fuge  (Beckman  Instruments,  Inc.,  Spinco  Div.,  Palo 
Alto, Calif.) (5 min, 4~  12,000 rpm). The cell pellets 
were  then postfixed with 2%  OsO4  in 0.1  M  sodium 
phosphate buffer, pH 7.3, dehydrated, and embedded in 
Araldite. 
All material for electron microscopy was sectioned on 
a Sorvall MT 2-B ultramicrotome (DuPont Instruments, 
SorvaU Operations, Newtown, Conn.), stained with ura- 
nyl acetate and lead  citrate, and viewed with either a 
Philips 200 or a Philips 300 electron microscope. 
Oil Red 0  Staining of Fibroblasts 
Fibroblast monolayers were grown on glass cover slips 
contained in Petri dishes. Cells were initially seeded on 
day 0  at a  concentration of  1  ￿  105 cells per dish as 
described above.  On  day  4  of  cell growth,  each  dish 
received 2 ml of growth medium containing 5% human 
lipoprotein-deficient serum and one of the following ad- 
ditions:  none;  native  LDL  at  a  concentration  corre- 
sponding to 10 p,g/ml  of LDL protein; or DMPA-LDL 
at a concentration corresponding to 10 p.g/ml  of LDL- 
protein. This growth medium was replaced with 2 ml of 
an identical medium on day 5. On day 6, each monolayer 
was washed three times with 3 ml of phosphate-buffered 
saline,  after  which  was  added  3  ml  of  fresh  growth 
medium containing 5 %  human lipoprotein-deficient se- 
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24 h, on day 7 the cover slips were removed, fixed with 
6%  paraformaldehyde  in  0.1  M  sodium  phosphate 
buffer, pH 7.3, washed with a solution containing 4.5% 
sucrose and 0.1 M sodium phosphate, pH 7.3, and then 
stained  with Oil  Red  O  (34).  The  cover  slips were 
counter-stained with double strength Harris hematoxylin 
stain for 10 min. 
RESULTS 
Chemical and Physical Characteristics 
of OMPA-LOL 
Previous studies have shown that DMPA-LDL 
exhibits a net positive charge at pH 8.6 and there- 
fore migrates toward the cathode, in the direction 
opposite from that of native LDL, when subjected 
to electrophoresis in agarose gel (2). This change 
in charge has been interpreted to indicate that the 
DMPA molecule was incorporated into LDL un- 
der the standard reaction conditions. To quanti- 
tate the number of DMPA residues incorporated 
into each mole of LDL-protein under these condi- 
tions,  we  have  employed  an  indirect approach 
using [14C]ethylenediamine, a commercially avail- 
able  radiolabeled compound, that,  like  DMPA, 
forms  amide  bonds primarily with  the  free  car- 
boxyl  groups  of  proteins  in  the  presence  of  a 
carbodiimide reagent (30). Accordingly, as shown 
in  Table  II,  a  preparation  of  native  LDL  was 
divided  into  two  aliquots,  one  of  which  was 
treated with DMPA under the standard reaction 
conditions.  Both  the  untreated  and  DMPA- 
treated preparations of LDL were then dialyzed, 
after  which  each  was  reacted  with 
[14C]ethylenediamine  in the presence of the carbo- 
diimide  reagent.  After  a  repeat  dialysis,  the 
amount of  [14C]ethylenediamine coupled to each 
LDL preparation was measured. In the LDL that 
had never been exposed to  DMPA, 290 mol of 
[14C]ethylenediamine were incorporated per mole 
of LDL-protein (assuming a molecular weight of 
500,000  for  LDL-protein  [31]).  On  the  other 
hand, in the LDL preparation that had been re- 
acted  previously  with  DMPA,  only  38  tool  of 
[14C]ethylenediamine could  subsequently be  in- 
corporated per mole of LDL-protein, The differ- 
ence between these two numbers, 252 mol/mol of 
LDL-protein, represents the apparent number of 
sites that had reacted with DMPA and hence were 
blocked  from  subsequent  reaction  with 
[~4C]ethylenediamine. Since  LDL  has  been  re- 
ported to contain about 360 mol of glutamic and 
aspartic acid  residues per  mole  of LDL-protein 
(35), the data in Table II suggest that -70%  of 
these  negatively charged  amino acids were  cou- 
pled to DMPA under the standard reaction condi- 
tions. These results are similar to those of Danon 
and coworkers who were able to link DMPA to 
28-60%  of  the  total  titratable  carboxylic  acid 
groups on ferritin under reaction conditions simi- 
lar to those of the current study (15). 
When subjected to  gel filtration on a  column 
containing 4% agarose gel, DMPA-LDL and na- 
TAaLE II 
Determination of  Available Sites on Plasma LDL for 
Carbodiimide-Mediated Cationization 
[~C]Ethylenediamine  incorporated  into 
LDL preparation  LDL 
cpm/mg LDL-protein  rnol/mol  LDL* 
Untreated (A)  23,000  290 
DMPA-treated (B)  2,980  38 
(A) -  (B)  20,020  252 
One aliquot of ~251-LDL (20 mg protein, sp act, 13.5 ￿ 
103 cpm/mg protein)  was treated  with DMPA  as de- 
scribed under Materials and Methods. Another aliquot 
of the same tzSI-LDL preparation was treated similarly 
except that no carbodiimide or DMPA was added. Both 
LDL preparations were then dialyzed for  18 h at 4~ 
against 6 liters of 0.15 M NaCI adjusted to pH 7, after 
which 400-/zl aliquots of  the  untreated  and DMPA- 
treated LDL preparations (each containing about 4 mg 
protein)  were  mixed  with 200  /zl  of  1.6  M 
[~C]ethylenediamine-HCl (4  ￿  104 cpm//~mol) at pH 
6.0. Next, 25 mg of 1-ethyl-3(3-dimethylaminopropyl)- 
carbodiimide HCI was added to each tube. Each reaction 
mixture was incubated at 24~  for 2 h and then at 4~ 
for 24 h, after which it was dialyzed sequentially at 4~ 
against 6 liters of 0.15 M NaCI for 5 h and 6 liters of 
buffer containing 20 mM Tris-chloride, pH 7.4, 0.15 M 
NaC1, 0.01% EDTA for 18 h. 1 ml of the final dialysate 
contained no detectable ~4C- or ~25I-radioactivity.  Each 
of the dialyzed LDL preparations was then analyzed for 
its content of t4C- and '25I-radioactivity.  The t4C-radioac- 
tivity was determined by counting an aliquot (50 p.l) in 
10 ml of Aquasol counting fluid containing 0.2% NCS 
Tissue Solubilizer  in a Packard scintillation  spectrometer 
(Packard Instrument Co.,  Inc., Downer's Grove, I11.). 
The  t2Sl-radioactivity  was  determined  by  counting an 
aliquot (50 /.d) in a well-type gamma counter.  Under 
these  conditions,  14.3%  of  12Sl-radioactivity  was  de- 
tected in the  ~4C  channel of the  Packard  scintillation 
counter. Results were corrected for this spillover. About 
95%  of  the  t4C-radioactivity in  the  dialyzed LDL 
preparations  was  precipitable by  10%  trichloroacetic 
acid  and  about  3%  of  the  ~:;-radioactivity was  ex- 
tractable into chloroform:methanol (2:1). 
* Assuming  a  molecular  weight of  LDL-protein  of 
500,000 (31). 
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1), indicating that the native and DMPA-coupled 
iipoprotein particles were similar in size. To pre- 
vent the DMPA-LDL from sticking to the agarose 
itself, it was necessary to conduct this gel filtration 
experiment in the presence of a high concentration 
of salt. 
The DMPA-LDL and native LDL had similar 
densities as determined by isopycnic density cen- 
trifugation in cesium chloride (data  not shown). 
The two  lipoproteins also had a  similar ratio of 
esterified  cholesterol  to  free  cholesterol  (2.3:1) 
and a similar ratio of total cholesterol to protein 
(1.6:1) after appropriate correction for the effect 
of DMPA on the  Lowry protein determinations 
(see  Materials  and Methods  and Table  I).  The 
DMPA-LDL retained its spherical shape as deter- 
mined by electron microscopy after negative stain- 
ing with uranyl acetate. The mean -+ 1 SD diame- 
ter of the DMPA-LDL particles was 243 -+ 32 ]k, 
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Chromatography  of  native  LDL  (A)  and 
DMPA-LDL (B) on Bio-Gel A 15 M. Native LDL (21.4 
mg protein) or I~I-DMPA-LDL (16.2 mg protein con- 
taining 2.7  x  106 cpm) in a total volume of 1.8 ml of 
buffer A (50 mM Tris-chloride, pH 7.4, and 1 M NaC1) 
was applied to a column packed with Bio-Gel A 15 M 
(bed dimensions, 1.6  ￿  65  cm), and the column was 
eluted with buffer A at 4~  The percentage of transmis- 
sion at 280 nm was measured using an LKB Uvicord 
Absorptiometer  (LKB Instruments,  Inc.,  Rockville, 
Md.), and the mean value for each 2 ml of fraction was 
plotted (A,O). The content of l~ZI-radioactivity  (￿9  was 
determined by counting a 50-/LI aliquot of each fraction. 
The void volume of the column was determined from the 
elution position of human plasma VLDL. 
a  value that was slightly smaller than the  mean 
diameter of a control preparation of native LDL 
particles  obtained from  a  different subject  and 
studied simultaneously (283 -+ 22). However, the 
value for the DMPA-LDL was within the range of 
reported  molecular diameters  for  normal  LDL 
particles (37). 1 
Binding of DMPA-LDL to the 
Plasma Membrane 
To determine the native distribution of negative 
charges on the  surface of the normal fibroblasts 
that were  used in these  studies, cell monolayers 
were  exposed  for  10  s  to  cationized ferritin, a 
visual probe that has been used in other cell types 
to localize membrane anionic sites (15, 29), Fig. 2 
shows  that  the  cationized ferritin was  unevenly 
distributed on the cell surface. Over most of the 
plasma membrane, clumps or piles of ferritin were 
separated by regions of membrane that bound no 
ferritin. The  cationized ferritin was  found  over 
"coated  regions"  of the  plasma membrane (16, 
18,  38)  as  well as  over  noncoated regions. An 
identical pattern of cationized ferritin binding was 
observed in the FH homozygote fibroblasts. 
In order to study the binding of DMPA-LDL to 
the  cell surface,  the  fibroblast monolayers were 
incubated  at  4~  with  either  native  LDL  or 
DMPA-LDL,  washed  extensively, and then  ex- 
posed to native ferritin (Fig. 3). In the cells previ- 
ously incubated with native LDL, no ferritin was 
observed to be bound at the cell surface (Fig. 3A 
and B). On the other hand, in the cells that had 
been previously treated with DMPA-LDL, ferritin 
cores adhered to clusters of amorphous, electron- 
dense  material  located  at  intervals  along  the 
plasma  membrane (Fig.  3 C-F).  These  clusters, 
which most likely represent aggregates of DMPA- 
LDL, were frequently observed to extend outward 
from the membrane (Fig. 3 D). The clustered dis- 
i It should be noted that  these measurements of LDL 
were performed after negative staining with uranyl ace- 
tate. Staining with uranyl acetate was found to be prefer- 
able to staining with phosphotungstate because the latter 
caused precipitation of the DMPA-LDL. When the two 
staining methods were compared directly using native 
LDL  from three  normal subjects, we  found  that  the 
uranyl acetate method gave consistently  larger diameters 
for the LDL particle (267 _+ 27,244 _+ 27, and 263 -+ 
26  ,~)  as  compared with the  standard  phospho- 
tungstate method  (212  _+  22,  207  _  22,  and  224  - 
36 ,~,, respectively). 
124  THE  JOURNAL  OF  CELL  BIOLOGY ￿9 VOLUME  74,  1977 FIGURE 2  Representative electron micrographs showing the distribution of cationized ferritin bound to 
the surface of normal fibroblasts. Monolayers of cells were grown and incubated with 320  /zg/ml of 
cationized ferritin for 10-20 s at room temperature as described under Materials and Methods. The cells 
were then fixed, embedded, and stained with uranyl acetate and lead citrate as described under Materials 
and Methods. The plasma membrane characteristically  showed a patchy distribution of bound cationized 
ferrifin (solid arrows) even when the  cells were exposed to  the  probe  for only  10  s.  A  more  even 
distribution of bound cationized ferritin was observed over coated regions of the plasma membrane (open 
arrows). Note that the ferdfin binding to noncoated regions of the plasma membrane was often several 
layers deep. Bars, 1000/~. x 45,500. 
tribution on the cell surface appeared to match the 
native distribution of anionic sites as determined 
by direct measurement of the  binding of cation- 
ized ferritin (Fig. 2). In addition to being located 
randomly along the smooth surface of the plasma 
membrane (Fig. 3 C and D), particles of DMPA- 
LDL were observed to occur over coated regions 
and coated  pits  (Fig.  3 E  and F).  These  coated 
regions have been noted to undergo endocytosis to 
form coated vesicles that then fuse with lysosomes 
(23). The coated regions have also been found to 
be the sites at which the high affinity receptors that 
bind native LDL are located (1, 23). 
Uptake and Degradation of 
Cell-Bound DMPA-LDL 
To  follow  biochemically the  fate  of  DMPA- 
LDL,  the  modified lipoprotein was labeled with 
125I. When  the  12~I-DMPA-LDL  was  incubated 
continuously with  monolayers of fibroblasts, the 
total amount of lipoprotein associated with the cell 
reached a  plateau within 5 h and did not change 
significantly over the ensuing 80 h (Fig. 4 A). On 
the other hand, during the interval between 5 and 
80 h  trichloracetic acid-soluble (non-iodide) lZSI- 
radioactivity was  excreted  continuously into the 
culture  medium  at  a  constant  rate  (Fig.  4A). 
From the steady-state data between 5 and 80 h, it 
could be calculated (9, 19) that the turnover time 
for cell-bound I~I-DMPA-LDL, i.e., the time in 
which the  amount of 125I-DMPA-LDL degraded 
was  equal  to  the  total  cellular content of  1251- 
DMPA-LDL, was about 50 h. 
The fate of the cell-bound 12~I-DMPA-LDL was 
BAsu ET AL.  Cationized Lipoproteins and Human Fibroblasts  125 FIGURE  3  Localization of the binding of DMPA-LDL to the cell surface of normal fibroblasts. Monolay- 
ers of cells were grown and incubated for 30 min at 4~  with either native LDL (A and B) or DMPA-LDL 
(C-F) at a concentration corresponding  to 9.4/~g/ml of LDL-protein, then washed extensively, and finally 
exposed to 5 mg/ml of native ferritin for 1 h at 4~  The cells were then fixed, embedded, and stained with 
uranyl  acetate and lead citrate as described under Materials and Methods. (A  and B)  Representative 
electron micrographs showing that native  ferritin  did not bind to  the  surface of cells  that  had been 
pretreated with native LDL. (C and D) Representative electron micrographs showing that native ferritin 
did bind to cells that had been pretreated with DMPA-LDL. The ferritin was observed in association  with 
patches of electron-dense material (arrows) that most likely correspond to aggregations of DMPA-LDL. 
(E) High magnification of a ferritin-containing coated re#on of surface membrane (arrow) from a cell 
treated with DMPA-LDL and native ferritin. (F) A view similar to Fig.  3 E except that the section was 
unstained. Bars, 1,000/~. (A-D) ￿  56,200; (E and F) ￿  72,000. I 
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FIGURE 4  Turnover of cell-bound DMPA-LDL in FH homozygote fibroblasts. On day 7 of cell growth, 
dishes of cells were chilled for 30 min at 4~  The medium in each dish was then replaced with 3 ml of 
growth medium containing 5% human lipoprotein-deflcient serum and 2 /.tg protein/ml of ~2~I-DMPA- 
LDL (498 cpm/ng), and the cells were incubated for 1 h at 4~  After this incubation, one group of dishes 
(A) was warmed to 37~  and further incubated without removing the growth medium containing the I~I- 
DMPA-LDL. A second group of dishes (B) was washed extensively (19) to remove unbound I~I-DMPA- 
LDL, after which 3 ml of warm growth medium containing 5% human lipoprotein-deficient  serum and no 
~zSI-DMPA-LDL was added to each dish and the cells were incubated at 37~  At the indicated time, the 
medium from dishes in groups A and B was removed and its content of trichloroacetic acid-soluble ~25I- 
radioactivity  was determined (A). The monolayers were washed extensively (19) and the amount of bound 
~zSI-radioactivity was determined (@). Each value represents the average of duplicate incubations. The 
amount of total cellular protein per dish showed <10% variation in individual dishes throughout each 
experiment. The average values for exp A and B were 239 and 209 p.g/dish, respectively. 
also followed by exposing the fibroblast monolay- 
ers to the lipoprotein for 60 min at 4~  washing 
the monolayers extensively, and then incubating 
the  cells at  37~  in the  absence of  125I-DMPA- 
LDL.  As shown in Fig. 4 B, under these condi- 
tions  the  cell-bound  l~I-radioactivity  declined 
asymptotically over  an  80-h  period  until about 
80% of the radioactivity had left the cells. During 
this interval, approx, one-half of the lzsI-radioac- 
tivity that left the cell could be accounted for as 
trichloroacetic acid-soluble (non-iodide) material 
in the culture medium (Fig. 4 B), and the remain- 
der was released into the medium in a form that 
was still precipitable with trichloroacetic acid. The 
experiments in Fig. 4 were conducted in cells from 
a FH homozygote in order to avoid any possible 
contribution by the LDL receptor to the observed 
effects. However, in other studies, quantitatively 
identical  results  were  obtained  with  fibroblasts 
from normal subjects. 
We have previously reported that the physio- 
logic LDL receptor on the surface of normal fibro- 
blasts can be destroyed by brief treatment of the 
monolayers with pronase or other proteolytic en- 
zymes  (19-21).  As  a  result,  such  treatment re- 
duces the rate at which normal fibroblasts are able 
to degrade lzSI-LDL (19). Table III shows that, in 
contrast to  the  inhibition of the  degradation of 
native  12~I-LDL, brief  treatment  of  fibroblast 
monolayers with  pronase  actually increased the 
rate  of  degradation  of  125I-DMPA-LDL.  These 
data support the previous conclusion that the en- 
try of DMPA-LDL into the cell does not involve 
the LDL receptor (2). To rule out the possibility 
that  the  enhanced  degradation  of  ~25I-DMPA- 
LDL after pronase treatment was due to the ac- 
tion of traces of pronase that may have remained 
in the Petri dish after the proteo[ytic treatment of 
cells, the ~zSI-labeled lipoproteins were incubated 
with the cells in the absence and presence of chlor- 
oquine, a drug that has previously been shown to 
inhibit the lysosomal degradation of LDL in mon- 
olayers of intact fibroblasts (5, 24,  27).  Chloro- 
quine inhibited the  degradation  of  ~SI-DMPA- 
LDL both before and after treatment of the cells 
with pronase, indicating that in both case the deg- 
radation was occurring within lysosomes. In a sep- 
arate control experiment, it was also shown that 
chloroquine at a concentration of 80/xM did not 
inhibit the degradation of ~2~I-LDL  or ~25I-DMPA- 
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Effect of Pronase Treatment on the Abifity of Nor- 
mal  Fibroblasts  to  Degrade  t251-LDL  and  125I- 
DMPA-LDL 
~2q-Lipoprot ein degraded 
(+) 
Prior treatment of  (-)  Chloro-  Chloro- 
Addition to medium  celts  quine  quine 
rig~rag protein 
125I-LDL  None  1,100  23 
12~I-LDL  Pronase  300  27 
1zSI-DMPA-LDL  None  428  53 
1zSI-DMPA-LDL  Pronase  1,500  77 
On day 7 of cell growth, each dish was washed once with 
2 ml of phosphate-buffered saline and then incubated at 
37~  for 40 min in 2 ml of growth medium containing no 
serum  and  either  no  pronase  or  6  p,g  of pronase  as 
indicated. Each dish was then washed twice with 2 ml of 
growth medium containing 10% human lipoprotein-defi- 
cient  serum,  after  which  was  added  2  ml  of  growth 
medium containing 2% human lipoprotein-deficient se- 
rum,  either no chloroquine or  75  /xM  chloroquine as 
indicated, and one of the following indicated additions: 5 
/zg protein/ml of t25I-LDL (397 cpm/ng) or 5/zg protein/ 
ml of t25I-DMPA-LDL (527 cpm/ng). After incubation 
for 2.5  h  at 37~  the content of trichloroacetic acid- 
soluble  t25I-labeled  degradative products in the culture 
medium was determined. Each value represents the av- 
erage of duplicate incubations. 
LDL by pronase itself when the lipoproteins were 
incubated directly with the proteolytic enzyme in 
vitro. 
Pathologic Accumulation of Cholesteryl 
Esters in Fibroblasts Incubated 
with DMPA-LDL 
In the experiment shown  in Fig. 5, normal fi- 
broblasts were incubated for 4 days in lipoprotein- 
deficient serum containing 14C-oleate and supple- 
mented with one of the following: no lipoproteins, 
native  LDL,  or  DMPA-LDL.  At  the  intervals 
indicated, groups of monolayers were harvested to 
determine the amount of ~4C-oleate  that had been 
incorporated into ~4C-phospholipids, 14C-triglycer- 
ides,  and  cholesteryl ~4C-oleate. The  data  show 
that fibroblasts incubated in the absence of lipo- 
proteins  actively  synthesized  triglycerides  and 
phospholipids and that the presence of either na- 
tive  LDL  or  DMPA-LDL  did  not  significantly 
affect these synthetic rates. On the other hand, as 
previously shown  (25), cells incubated in the ab- 
sence  of lipoproteins incorporated  only  a  trace 
amount  of  t4C-oleate  into  cholesteryl  14C-oleate. 
In  the  presence  of  native  LDL,  a  significant 
amount  of  cholesteryl  14C-oleate  synthesis  oc- 
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FIGURE  5  Incorporation of x4C-oleate into cellular lip- 
ids in normal fibroblasts incubated with native LDL and 
DMPA-LDL.  Cell  monolayers  were  prepared  as  de- 
scribed under Materials and Methods. On day 1 of cell 
growth,  each  dish  received  3  ml  of  growth  medium 
containing 10% calf lipoprotein-deficient serum. On day 
3 (zero time), each dish received 2 ml of growth medium 
containing 5% calf iipoprotein-deficient serum, 0.1 mM 
t~C-oleate-albumin  (10,000  cpm/nmol),  and  the  indi- 
cated addition (0, none; A, 10/.Lg protein/ml of native 
LDL; or l,  10 /zg protein/rnl of DMPA-LDL).  Every 
24 h  throughout the experiment, the medium in each 
dish was replaced with fresh medium containing 0.1 mM 
14C-oleate-albumin and the indicated lipoprotein. At the 
indicated time, the cell monolayers in each group were 
harvested and their content of cholesteryl t4C-oleate (A), 
t4C-triglycerides  (B), and 14C-phospholipids  (C) was de- 
termined by thin-layer chromatography as described in 
Materials and Methods. Each value represents the aver- 
age of triplicate incubations. 
128  THE  JOURNAL OF  CELL BIOLOtV'  VOLUME 74,  1977 curred on the first day. However, on subsequent 
days no further increase in the cellular content of 
cholesteryl  ~4C-oleate  occurred  (Fig.  5 A).  We 
have previously shown that this cessation in net 
cholesteryl ester  synthesis, which  occurs despite 
the  continued presence  of  both  LDL  and  ~4C- 
oleate in the  culture medium, is due to the fact 
that the initial accumulation of cholesterol on the 
first day leads to  a  subsequent reduction in the 
number of LDL receptors (28). Thus, the rate of 
uptake of native LDL is markedly reduced after 
the first day. The accumulation of cholesterol de- 
rived from DMPA-LDL also produced a  reduc- 
tion in the  number of LDL receptors  (data  not 
shown).  However,  since  the  cellular  entry  of 
DMPA-LDL does not decrease when the number 
of LDL receptors becomes suppressed (2), its up- 
take continued steadily for the 4 days of this ex- 
periment, and  the  cells continued to  synthesize 
and accumulate cholesteryl ~4C-oleate in a linear 
fashion (Fig. 5 A). 
Further evidence of the abnormal accumulation 
of  cholesteryl  ester  in  fibroblasts  exposed  to 
DMPA-LDL was obtained from measurements of 
the total cellular content of esterified cholesterol 
by gas-liquid chromatography (Fig. 6 B). This ex- 
periment also showed that, whereas native LDL 
had  little  effect  on  the  cellular content of  free 
cholesterol,  DMPA-LDL  caused  a  marked  in- 
crease in the content of free cholesterol in the cell 
(Fig. 6 A). 
The data in Table IV show that under condi- 
tions in which the cellular content of cholesteryl 
esters was 36-fold higher in cells grown in DMPA- 
LDL  as  compared  with  those  grown  in  native 
LDL, the content of cellular triglyceride was the 
same under both circumstances. 
The pathologic accumulation of cholesteryl es- 
ters that occurred in fibroblasts grown in DMPA- 
LDL could be  detected morphologically at both 
the light microscope and electron microscope lev- 
els. In preliminary experiments, it was noted that 
when  fibroblasts  were  incubated  with  DMPA- 
LDL, washed, and then stained immediately with 
Oil Red O, clumps of Oil Red O-positive material 
that  presumably  represented  DMPA-LDL  ap- 
peared on the surface of the cells, obscuring the 
visualization of lipid droplets within the cell. Ac- 
cordingly, for the morphologic studies, cells were 
incubated for 48 h with DMPA-LDL, after which 
they were incubated for 24 h in lipoprotein-defi- 
cient serum to  allow endocytosis of the  surface- 
bound clusters of DMPA-LDL.  Fig.  7A  and B 
show that cells incubated either in the absence of 
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FIOURE 6  Accumulation of free (A) and esterified (B) cholesterol in normal fibroblasts incubated with 
native LDL and DMPA-LDL. Cell monolayers were prepared as described under Materials and Methods. 
On day 1 of cell growth, each dish received 3 ml of growth medium containing 10% calf lipoprotein- 
deficient serum. On day 3 (zero time), each dish received 2 ml of growth medium containing 5% calf 
lipoprotein-deficient  serum and the indicated addition (O, none; A, 10 ~g protein/ml of native LDL; or II, 
10/zg protein/ml of DMPA-LDL). Every 24 h throughout the experiment, the medium in each dish was 
replaced with fresh medium containing the  indicated lipoprotein.  At  the  indicated time,  three  cell 
monolayers in each group were washed, harvested, and pooled, and their content of free (A) and esterified 
cholesterol (B) was determined. Each value represents the average of duplicate samples (three monolayers 
per sample). 
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Failure of DMPA-LDL to Elevate the Triglyceride 
Content  of Normal Human Fibroblasts 
Cholesterol  content 
Addition  to me-  Triglyceride 
dium  Free  Esterified  content 
lag stool/rag protein  lag~rag  protein 
Native LDL  32  1.0  19 
DMPA-LDL  48  36  19 
On day 0, 1.5 x  10  ~ cells were seeded into each 100 x 
20 mm Petri dish containing 7 ml of growth medium with 
10% fetal calf serum. On day 3, each monolayer was 
washed with 5 ml of phosphate-buffered saline and the 
dishes were divided into two groups. In one group, each 
of 15 dishes received 7 ml of growth medium containing 
5% calf lipoprotein-deficient  serum and 6/xg protein/ml 
of native LDL. In the other group, each of 15 dishes 
received 7  ml of growth medium containing 5%  calf 
lipoprotein-deficient serum  and  6  /zg  protein/ml  of 
DMPA-LDL. After incubation for 72 h at 37~  the cell 
monolayers in each group were washed, harvested and 
pooled, and frozen at -20~  The lipids of the thawed 
cells were extracted  with chloroform:methanol (2:1). 
The content  of free and esterified cholesterol and of 
triglyceride was  determined  as  described in Materials 
and Methods. Each value represents the average of du- 
plicate determinations. 
lipoproteins or in the presence of native LDL did 
not accumulate significant lipid droplets that could 
be detected by staining with Oil Red O. On the 
other  hand,  in  the  same  experiment cells incu- 
bated in the presence of DMPA-LDL contained 
large numbers of lipid droplets that were stained 
with Oil Red O  (Fig. 7 C). Although the number 
of such lipid droplets varied from cell to ceil, each 
cell treated  with DMPA-LDL exhibited at least 
some stainable lipid droplets. 
Electron microscope examination of fibroblasts 
treated with DMPA-LDL showed that many cells 
had  accumulated large  numbers of neutral lipid 
droplets that lacked a tripartite limiting membrane 
(Fig.  8A).  In those  cells with large  numbers of 
droplets, the lipid appeared to be associated with 
cytoplasmic areas that were devoid of ground sub- 
stance (Fig. 8 B). In contrast to the DMPA-LDL 
effect, fibroblasts treated with an equal amount of 
native LDL  under the  same  conditions showed 
only an occasional lipid droplet and did not show 
areas devoid of ground substance. 
DISCUSSION 
Plasma LDL that had been rendered polycationic 
by covalent linkage with the tertiary amine DMPA 
has been shown by electron microscopy to bind in 
large amounts to widespread sites on the plasma 
membrane of human fibroblasts. The pattern of 
DMPA-LDL binding corresponded to the pattern 
of polycationic ferritin binding in the same cells, 
suggesting that the  DMPA-LDL was binding to 
anionic sites on the  cell surface  (15,  29).  Once 
DMPA-LDL had bound to the cell surface, it was 
taken up and hydrolyzed by the cell at a relatively 
slow rate so that an amount of DMPA-LDL equal 
to the steady-state content was degraded every 50 
h (Fig. 4 A). The true turnover time for the cell- 
bound DMPA-LDL may actually be  faster than 
50 h since some of the t25I-DMPA-LDL measured 
as being cell-bound might in fact have been bound 
to inert sites on the proteinaceous matrix between 
the cells and hence not susceptible to internaliza- 
tion and degradation. However, at the low con- 
centration of DMPA-LDL used (2 /zg/ml), bind- 
ing to the culture dish in the absence of cells (2) 
was minimized. Moreover, the pulse-labeling ex- 
periment in Fig. 4 B showed that at least 40% of 
the bound lzsI-DMPA-LDL was located at sites in 
which  it  was  susceptible to  cellular degradation 
and hence probably on or within the ceil. 
Compared with the  specific receptor-mediated 
uptake and degradation process for native LDL, 
the nonspecific uptake process for DMPA-LDL is 
extremely inefficient. Thus, as previously shown, 
when lzSI-LDL binds to the LDL receptor, essen- 
tially all of the cell-bound 125I-LDL is internalized 
within 12 min and degraded within 90 min (9, 18, 
23)  as contrasted with the  25-50 h  required to 
clear the  cell surface of lzSI-DMPA-LDL. How- 
ever, since the  amount of ~25I-DMPA-LDL  that 
binds  to  the  anionic  sites  is  at  least  100-fold 
greater than the amount ~z~I-LDL that can bind to 
the  limited number of specific  cell surface LDL 
receptors (19), the absolute rate of internalization 
and  degradation  of  DMPA-LDL  can  actually 
equal the maximal rate of internalization  and deg- 
radation of native LDL. 
With regard to cellular cholesterol metabolism, 
the  most  interesting aspect  of the  DMPA-LDL 
uptake process is that it is immune to the type of 
feedback  regulation that  governs the  uptake  of 
LDL  by  the  physiologic  LDL  receptor  mecha- 
nism. Thus, when fibroblasts accumulate sufficient 
cholesterol to satisfy their requirements for mem- 
brane synthesis, the cells suppress the number of 
LDL receptors, reducing the rate of LDL uptake 
and  preventing an  overaccumulation of  choles- 
terol  (9,  28).  On  the  other  hand,  the  uptake 
130  THE  JOURNAL  OF  CELL  BIOLOGY" VOLUME  74,  1977 FIGURE  7  Monolayers of normal fibroblasts stained with Oil Red O  to show accumulated cytoplasmic 
lipid and with hematoxylin to show nuclei. Cell monolayers were grown on glass cover slips and incubated 
with one of the following lipoprotein preparations as described under Materials and Methods: (A) none; 
(B) native LDL;  or  (C)  DMPA-LDL.  After these incubations, the cells were  incubated for  24  h  in 
lipoprotein-deficient serum  without lipoproteins,  after which  they  were  stained  with  Oil  Red  O  and 
counter-stained with  Harris  hematoxylin  stain  as  described under  Materials  and  Methods.  The  dark 
granules, which only accumulated in cells treated with DMPA-LDL (C), represent regions of Oil Red O 
staining. Bars (A and C), 10/xm; (B), 6.6 /.tm. (A) ￿  525; (B) x  700; (C)  x  475. FmURE  8  TWO electron  micrographs of fibroblasts  treated  with  DMPA-LDL.  Cell monolayers were 
grown, incubated with 10 p.g protein/ml of DMPA-LDL for 2 days as described in the legend to Fig. 6, and 
then incubated for 24 h  in lipoprotein-deficient serum without DMPA-LDL. The electron micrographs 
show that the cells have accumulated neutral lipid droplets that lack a tripartite limiting membrane.  In 
some  cells,  the  accumulation  of  lipid  droplets  appeared  to  have  disrupted  the  normal  cytoplasmic 
organization. Note the accumulation of electron-dense material (arrows) on the surfaces  of DMPA-LDL 
treated cells; this material is most likely aggregates of DMPA-LDL. Bars, 2,000 A. (A) ￿  14,000; (B) ￿ 
22,300. 
process  for  DMPA-LDL  is  not  reduced  when 
LDL receptor activity is suppressed  (2),  and thus 
cells  can  be  forced  to  accumulate  pathologic 
amounts of cholesteryl esters. 
On the basis of the experiment in Fig. 5 showing 
a continuous incorporation of ~4C-oleate into cho- 
lesteryl  14C-oleate  over 4  days  in  cells incubated 
with DMPA-LDL, it seems clear that a portion of 
the  cellular  cholesteryl  esters  accumulates  as  a 
result  of  esterification  within  the  cell.  The  free 
132  THE  JOURNAL OF  CELL BIOLOGY" VOLUME 74,  1977 cholesterol substrate for this esterification reaction 
is derived from  the  lysosomal hydrolysis of the 
cholesteryi esters of DMPA-LDL, as indicated by 
the  observation  that  mutant  Cholesteryl  Ester 
Storage  Disease  cells,  which lack  the  lysosomal 
acid lipase enzyme (27), did not exhibit a normal 
enhancement in cholesteryl ester formation when 
incubated with  DMPA-LDL  (data  not  shown). 
These  data  are  similar to  those  previously ob- 
tained in  normal fibroblasts with  the  lysosomal 
enzyme inhibitor chloroquine (2). 
The  data  in  Fig.  4A  show  that  when  I~sI- 
DMPA-LDL is incubated with fibroblasts, a  dy- 
namic steady state is achieved in which the cellular 
content of lz~I-DMPA-LDL remains constant over 
three  days but in which  the  degradation of the 
lipoprotein continues at a linear rate. Despite an 
unchanging content of intact DMPA-LDL, total 
cholesteryl esters (Fig. 6 B) and cholesteryl esters 
newly synthesized from 14C-oleate (Fig. 5 A) con- 
tinue to accumulate in parallel with the degrada- 
tion of the protein component of the DMPA-LDL 
(Fig. 4 A). Considered together,  these data sug- 
gest that as the intact membrane-bound DMPA- 
LDL is transferred intracellularly,  its protein com- 
ponent is  hydrolyzed  and  the  resultant radiola- 
beled degradative products (including mainly ~25I- 
monoiodotyrosine [20]) are excreted by the cell. 
On the other hand, the cholesteryl esters of the 
degraded  DMPA-LDL  continue  to  accumulate 
within the cell. Some of the accumulated choles- 
teryl esters are derived from cholesteryl esters that 
have been hydrolyzed and reesterified as discussed 
above, and some represent intact cholesteryl es- 
ters  that  have  not  been  hydrolyzed.  Since  the 
experiments described in Figs. 5 and 6 were car- 
ried out under identical conditions, a comparison 
of these  data  allows a  minimal estimate  of  the 
proportion of accumulated cholesteryl esters that 
is attributable to cholesterol that had been esteri- 
fled  within  the  cell.  Thus,  on  day  3  the  total 
cellular content of esterified cholesterol  was  70 
p,g/mg protein (Fig. 6 B). On the other hand, Fig. 
5 A  shows that on day 3  -36 nmol of ~4C-oleate 
had been incorporated into cholesteryl esters per 
mg protein. This latter value is equivalent to 14 ~g 
of cholesterol that had been attached to 14C-oleate 
per mg protein. Thus, out of a total accumulation 
of cholesteryl esters equal to 70 p,g/mg, at least 14 
/~g/mg  (or  20%)  represented  newly synthesized 
cholesteryl esters. This figure is likely to be a slight 
underestimate  since  the  cell  also  attaches  fatty 
acids other than oleate to cholesterol under these 
circumstances (5, 27). Of the -80% of cholesteryl 
esters that had apparently not been hydrolyzed by 
the cell, a portion may reflect intact DMPA-LDL 
that was bound to the plasma membrane and that 
had not yet entered the cell. However, since the 
accumulation of cholesteryl esters was progressive 
with time whereas the amount of intact cell-bound 
12~I-DMPA-LDL was constant (Fig. 4 A), it seems 
likely that much of the nonhydrolyzed cholesteryl 
esters  represents  DMPA-LDL  that had  entered 
the  cell  where  its  protein  component had  been 
hydrolyzed but where its cholesteryl ester compo- 
nent either was trapped within cellular lysosomes 
or had escaped from lysosomes to form lipid drop- 
lets. 
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